Lived Experience of Lung Transplantation

  • Research type

    Research Study

  • Full title

    Lung Transplantation in the Twenty First Century: The lived experience of patients who received transplanted lungs between 1985 and 2000.

  • IRAS ID

    288853

  • Contact name

    Paula Rogers

  • Contact email

    p.rogers@rbht.nhs.uk

  • Sponsor organisation

    University of Northampton

  • Duration of Study in the UK

    1 years, 5 months, 30 days

  • Research summary

    Lung transplantation is an established treatment for patients with end-stage lung disease (Langer, 2015). During the last two decades, considerable advances in organ preservation, surgical techniques, immunosuppression and anti-biotic therapy have contributed to an improvement in post-operative survival. Adults who received a lung transplant in the era from January 1990 to June 2012 (n = 41,767), had a median survival of 5.7 years (Yusen et al, 2014). Overall survival from 2012 to 2016 has increased to a median survival of eight years, conditional on surviving the first-year post transplant surgery (Yusen et al, 2016).

    One of the main determinants of lung transplantation outcome is the underlying disease, with a median survival of 8.9 years for cystic fibrosis patients, 6.7 years for chronic obstructive pulmonary disease with alpha-1 antitrypsin deficiency, 5.6 years for patients with chronic obstructive pulmonary disease without alpha-1 antitrypsin deficiency, 4.8 years for patients with idiopathic interstitial pneumonia and 2.8 years for re-transplantation (Thabut and Mal, 2017). The main focus of post-operative management is to develop care pathways which improve exercise capacity, independent functioning and increase quality of life (Myaskovsky et al, 2006; Smeritschnig et al, 2005; Gerbase et al, 2008).

    A recent review undertaken within a tertiary centre for cardiothoracic care has evaluated the totality of lung transplantation since the programme began in 1983. There are seventy patients who have survived a lung transplant for twenty years or more and there are signs that this lung transplant population may have additional care needs compared to a younger, less complex population of lung transplant patients.

    Having raised the profile of this patient group with a lung transplant, this has strengthened the author’s desire, who is a nurse working within the Centre, to understand more about the implications of living with a transplanted lung for more than twenty years Therefore, the aim of this proposed study is to explore the lived experience of patients who have survived a lung transplant for at least twenty years.

  • REC name

    Wales REC 6

  • REC reference

    20/WA/0331

  • Date of REC Opinion

    2 Dec 2020

  • REC opinion

    Favourable Opinion